Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against... Read More
Algernon Receives Clearance From Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has received a “No Objection” letter... Read More
Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus
Evotec SE, a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, announced... Read More
New Molekule Air Mini+ Keeps Your Home’s Air Clean Automatically
It’s been weeks and, more than any place else, your home is where you’ve spent the majority of your time. Is it... Read More
Foundation Park Building Sells for $12M
Avison Young real estate services announced the sale of a $12 million, newly-constructed 43,180-square-foot biotech and life science research facility at Foundation... Read More
A Blood Test to Detect Traumatic Brain Injury
Traumatic brain injury (TBI) is hard to detect, and is sometimes called the “invisible injury.” Ron Hayes and Nancy Denslow, both scientists... Read More
Unique Sensors Will Improve Aerodynamic Design, Aircraft Performance
Even after almost 150 years of wind tunnel testing, no commercial product had ever been able to directly measure the localized force... Read More
Full Interview: Algernon Pharmaceuticals Receives OK From South Korea for Phase Two Study of Ifenprodil
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive in Vancouver with big news.... Read More
Ology Bioservices to Adapt Veroplex Cell Platform for Rapid Response to Viral Threats for Department of Defense
The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract... Read More
Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has submitted a Clinical Trial Application... Read More
